River AI
River AI Raises $1.1B Series Seed and Series A for Personal AI
River AI announced $1.1B in Series Seed and Series A financing on August 11, 2026. River AI announced $1.1 billion in Series Seed and Series A funding led by General Catalyst and AMP PBC to build personal AI across training infrastructure, products, and hardware.
Round details
The financing includes backing from General Catalyst, AMP PBC, NVIDIA, AMD Ventures, Y Combinator, Temasek. The company did not publish a valuation with the announcement.
- Round: Series Seed and Series A
- Capital announced: $1.1B
How the company plans to use the capital
River AI said it will build the full stack end to end, including training infrastructure that makes fine-tuning accessible to any developer, products built around personalization and continual learning, and new hardware for personal AI. The company said the funding accelerates every layer of that stack.
Why this matters for GTM teams
The round points to large-scale investor interest in personal AI and in developer tooling for fine-tuning open-weight models, with the company planning to build across training infrastructure, products, and hardware.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: River AI Series Seed and Series A announcement.
Company Info
Investors (6)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


